Vanberra Signal

MiLaboratory

Curated by Signal

Software solutions for immune repertoire profiling

Overview

MiLaboratory develops software solutions for the deep error-free profiling of immune receptor repertoires (RepSeq) by NGS to enable applications such as studies of autoimmunity, vaccination, immunotherapy, hypersensitivity, checkpoint inhibitors (monoclonal antibodies), tumor infiltrating lymphocytes, T cell therapy, minimal residual disease, and adaptive immunity aging. The companies products include MiXCR (a universal software for fast and accurate analysis of T- and B-cell receptor repertoire high-throughput sequencing data), VDJTools (software for comprehensive comparative post-analysis of T-cell receptor repertoires), MIGEC (software for molecular barcoded T- and B-cell receptor repertoire high-throughput sequencing data analysis).

Key facts

Founded
2012
Headquarters
Moscow, Russia

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of communication solutions for disabled people

    Health TechnologyMoscow, Russia
  • Online platform for the purchase of medicines

    Health TechnologyKhabarovsk, Russia
  • Provider of a dental management software for dental clinics

    Health TechnologyPushkino, Russia

About MiLaboratory

What does MiLaboratory do?

MiLaboratory develops software solutions for the deep error-free profiling of immune receptor repertoires (RepSeq) by NGS to enable applications such as studies of autoimmunity, vaccination, immunotherapy, hypersensitivity, checkpoint inhibitors (monoclonal antibodies), tumor infiltrating lymphocytes, T cell therapy, minimal residual disease, and adaptive immunity aging.

Where is MiLaboratory headquartered?

MiLaboratory is headquartered in Moscow, Russia.

When was MiLaboratory founded?

MiLaboratory was founded in 2012.

Which sector is MiLaboratory in?

MiLaboratory operates in Health Technology.

Who are MiLaboratory's competitors?

Companies similar to MiLaboratory include NeuroChat, New Pharmacy, and Future IT Dent.